Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • mylan

    Tag: mylan

    You Searched For "mylan"
    Mylan, Lupin Announce Positive CHMP Opinion for Nepexto

    Mylan, Lupin Announce Positive CHMP Opinion for Nepexto

    Medical Dialogues Bureau29 March 2020 8:02 AM GMT
    Hertfordshire, Pittsburgh, and Mumbai: Mylan N.V. and Lupin Limited (Lupin) has announced that the European Medicines Agency's Committee for Medicinal ...
    NPPA directs 3 pharma cos to maintain stock of atleast 2.2 crore tablets of FDC Lopinavir and Ritoavir

    NPPA directs 3 pharma cos to maintain stock of atleast 2.2 crore tablets of FDC Lopinavir and Ritoavir

    Medical Dialogues Bureau29 March 2020 7:49 AM GMT
    New Delhi: The National Pharmaceuticals Pricing Authority (NPPA), Department of Pharmaceuticals directed 3 major manufacturers of the HIV Combo...
    Mylan, Pfizer Upjohn merger gets delayed in light on coronavirus

    Mylan, Pfizer Upjohn merger gets delayed in light on coronavirus

    Medical Dialogues Bureau28 March 2020 8:00 AM GMT
    Hertfordshire & Pittsburgh: Mylan N.V. and Pfizer Inc. today announced that due to the unprecedented circumstances surrounding the COVID-19 pandemi...
    Biocon, Mylan win patent rights for Insulin Glargine Device against Sanofi

    Biocon, Mylan win patent rights for Insulin Glargine Device against Sanofi

    Medical Dialogues Bureau12 March 2020 5:59 AM GMT
    Insulin Glargine is a long-acting insulin used to treat adults with Type 2 diabetes and adults and paediatric patients with Type 1 diabetes for the...
    USFDA Accepts Biocon, Mylans application for review of   Proposed Biosimilar of Bevacizumab

    USFDA Accepts Biocon, Mylan's application for review of Proposed Biosimilar of Bevacizumab

    Medical Dialogues Bureau10 March 2020 7:45 AM GMT
    Biocon Ltd. and Mylan N.V. announced that the U.S. Food and Drug Administration (FDA) has accepted Mylan's Biologics License Application (BLA)...
    Mylan warns of possible drug shortages, financial hit due to coronavirus

    Mylan warns of possible drug shortages, financial hit due to coronavirus

    Medical Dialogues Bureau29 Feb 2020 4:00 AM GMT
    Although heavily reliant on China, the company said it was better positioned against the impact of the outbreak compared to its peers due to its...
    Sanjeev Narula CFO Pfizer Upjohn  appointed as incoming CFO of Viatris

    Sanjeev Narula CFO Pfizer Upjohn appointed as incoming CFO of Viatris

    Medical Dialogues Bureau28 Feb 2020 8:15 AM GMT
    Viatris is the new company that will result from the planned combination of Mylan and Upjohn
    FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis

    FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis

    Medical Dialogues Bureau24 Dec 2019 4:15 AM GMT
    Sales of Eliquis, which Bristol-Myers co-developed with Pfizer, rose 22% to $1.93 billion and made up about 30% of the Bristol-Myers' total revenues in...
    Mylan, Pfizer say Mylan-Upjohn combined entity to be known as Viatris

    Mylan, Pfizer say Mylan-Upjohn combined entity to be known as Viatris

    Medical Dialogues Bureau16 Nov 2019 3:50 AM GMT
    New Delhi: Mylan N.V. and Pfizer Inc. recently announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn, ...
    NPPA fixes retail price of 14 drug formulations; Details

    NPPA fixes retail price of 14 drug formulations; Details

    Farhat Nasim13 Nov 2019 5:53 AM GMT
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    Novartis gets U.S. nod for long-delayed copycat version of Amgen billion seller Neulasta drug

    Novartis gets U.S. nod for long-delayed copycat version of Amgen billion seller Neulasta drug

    Medical Dialogues Bureau6 Nov 2019 5:02 AM GMT
    ZURICH: Novartis on Tuesday won U.S. approval for its long-delayed version of Amgen's $4 billion seller Neulasta drug, helping the Swiss drugmaker in...
    Pfizer cancer drug Ibrance higher sales beat Q3 profit estimates

    Pfizer cancer drug Ibrance higher sales beat Q3 profit estimates

    Medical Dialogues Bureau30 Oct 2019 4:00 AM GMT
    Pfizer said it expects to earn between $2.94 per share and $3.00 per share, up from a prior estimate of $2.76 to $2.86. Analysts on average were expect...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 27 May 2022 6:45 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
    verify here.

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
    X
    X